RNA-Sequencing Combined With Genome-Wide Allele-Specific Expression Patterning Identifies ZNF44 Variants as a...

Area of Science:

• Pediatric Oncology
• Cancer Genomics
• Molecular Biology

Background:

• Neuroblastoma (NB) is a significant pediatric malignancy, causing substantial childhood cancer mortality.
• Somatic mutations in genes like ALK are implicated in NB progression and therapeutic target discovery.
• Limited research exists on the differential expression of mutated versus wild-type alleles in NB transcriptomes.

Purpose of the Study:

• To analyze somatic mutations in neuroblastoma.
• To investigate allele-specific expression of these mutations.
• To identify novel driver genes for neuroblastoma.

Main Methods:

• Whole-exome sequencing of 219 paired normal and tumor neuroblastoma samples.
• Mutation detection using MuTect.
• Integrated analysis of 127 RNA-seq and 85 DNA-seq samples to confirm allele-specific expression.

Main Results:

• Prioritized 8 candidate driver genes, including ALK, MYCN, and PTPN11.
• Confirmed allele-specific expression for mutations in MYCN, ALK, and PTPN11.
• Identified two novel ZNF44 variants as potential driver mutations in NB.

Conclusions:

• ZNF44 is proposed as a novel candidate driver gene for neuroblastoma.
• Allele-specific expression of mutations may influence clinical outcomes in NB.
• Further research into ZNF44 variants could reveal new therapeutic strategies for neuroblastoma.